Marc Van Den Eynde

Marc Van Den Eynde

Université Catholique de Louvain - Louvain-la-Neuve / Belgium
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1409187
Catholic University of Louvain
person_outline Marc Van Den Eynde's MOST POPULAR ARTICLES
1-) International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyF Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...The Lancet 391 (10135), 2128-2139, 201813552018
2-) Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal …A Hendlisz, M Van den Eynde, M Peeters, G Maleux, B Lambert, ...J Clin Oncol 28 (23), 3687-3694, 20104602010
3-) Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised …C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ...The lancet oncology 20 (6), 849-861, 20193012019
4-) Evolution of metastases in space and time under immune selectionM Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ...Cell 175 (3), 751-765. e16, 20183952018
5-) Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised …CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ...The Lancet Oncology 20 (3), 420-435, 20192622019